United States · FDA National Drug Code directory
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72516-016_5734011d-5044-b490-e063-6394a90a3174
- Product NDC
- 72516-016
- Form
- TABLET
- Composition / generic term
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
- Labeler
- Oryza Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201019
- Source listing expiry
- 20271231
Source-listed ingredients
- DEXTROAMPHETAMINE SACCHARATE — 1.25 mg/1
- AMPHETAMINE ASPARTATE MONOHYDRATE — 1.25 mg/1
- DEXTROAMPHETAMINE SULFATE — 1.25 mg/1
- AMPHETAMINE SULFATE — 1.25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (72516-016-01) · 72516-016-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →